Acadia Pharma
ACAD----
Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Preview: Acadia Pharma(ACAD) predict that the Revenue is 268.06 M (+9.72%), Miss estimate;the EBIT is -4.616 M (-123.9%), Miss estimate;the EPS is 0.02 (-81.82%), Miss estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueMiss expectations
0.27B9.72%
0.28B14.71%
-0.01B4.99%
EBITMiss expectations
-0.00B123.93%
0.00B74.51%
-0.01B49.42%
EPSMiss expectations
0.0281.82%
0.048156.25%
-0.028125.57%
Upcoming earnings report - FY2026 Q2 Earning Release
Available dateAug 4, 2026
Estimate Revenue295.52 M
Estimate EBIT4.255 M
Estimate EPS0.0699
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf